James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
In this video, Dr Bruce Sands discusses the current role of JAK inhibitors for the treatment of IBD and whether or not gastroenterologists should be concerned with adverse events.
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only be effective...
